117 results
Thumbnail

D1.362 - Exploratory Efficacy, Pharmacokinetics, Pharmacodynamics and Safety of YH35324, a Long-Acting high-affinity IgETrap-Fc protein, in Patients with Chronic Spontaneous Urticaria Refractory to Omalizumab

Thumbnail

D1.363 - Efficacy and safety of Mepolizumab in treatment of eosinophilic granulomatosis with polyangiitis

Thumbnail

D1.364 - Update on the Observed incidence of Anaphylaxis and Serum Sickness in Patients Receiving Omalizumab in a Canadian Tertiary Allergy/Asthma Clinic

Thumbnail

D1.365 - ZL-1503: A Bispecific Antibody Targeting Inflammatory and Pruritogenic Pathways with a Prolonged Serum Half-life and Sustained Activity in Non-human Primates

Thumbnail

D1.390 - Long-term safety and efficacy of navenibart in participants with hereditary angioedema (HAE): Initial combined results from ALPHA-STAR and ALPHA-SOLAR

Thumbnail

D1.366 - Improvement Over Time in Specific Aspects of Quality of Life in Patients with Chronic Spontaneous Urticaria Treated with Omalizumab

Thumbnail

D1.367 - Dupilumab for refractory pruritus in hematological and non-hematological malignancies – preliminary results

Thumbnail

D1.368 - Anti-interleukin-5 treatment in patients with severe eosinophilic asthma provides consistent symptom control for at least 8 years

Thumbnail

D1.369 - Characteristics of patients with severe asthma undergoing biological treatment at a reference center

Thumbnail

D1.371 - Dupilumab for the treatment of refractory severe chronic spontaneous urticaria

Thumbnail

000594 - The Role of Asthma and COVID-19 in Shaping the Severity of Pediatric Mycoplasma pneumoniae Infections: A Regional Perspective from the United States

Thumbnail

100094 - A Mycoplasma pneumoniae infection in an alergic preschool-aged child. Case report

Thumbnail

100334 - Chryseobacterium indologenes: An emerging bacteria with antiviral properties

Thumbnail

100514 - Chronic urticaria and eradication of helicobacter pillory-evaluation of treatment results

Thumbnail

D1.127 - Distinct roles of Natural killer T Cells and Innate Lymphoid Cells in Type I and II airway Inflammation Induced by Viral Infection

Thumbnail

D1.396 - Identifying Allergies, Prematurities, and GERD as Risk Factors for Recurrent Respiratory Infections in Children: A Case-Control Study

Thumbnail

D2.131 - Classification, early determinants and long-term impact on asthma of the IgG responses to rhinovirus VP1 (RV-VP1): a longitudinal study in two birth cohorts

Thumbnail

D2.342 - Changes of MMP-9 and MMP-12 in response of acute viral infection in virtual model of macrophages

Thumbnail

- D3.124 - Severe asthma associated with hereditary angioedema type 1 and other pathologies

Thumbnail

- D3.128 - THE BACK COVER OF ASTHMA: Retrospective case-report of a 21-year-old woman